In addition, miR-875-5p also inhibited cyclin D1, cyclin D2 and promoted p57 and p21 expression levels in CRC cells, which further contributed to the growth-delay efficacy of miR-875-5p. Here, CCND2 is linked to colorectal carcinoma.